• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'.

作者信息

Jain Siddharth, Dhir Varun

机构信息

Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

出版信息

Ann Rheum Dis. 2023 Jul;82(7):e162. doi: 10.1136/annrheumdis-2021-220816. Epub 2021 Jun 30.

DOI:10.1136/annrheumdis-2021-220816
PMID:34193404
Abstract
摘要

相似文献

1
Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'.
Ann Rheum Dis. 2023 Jul;82(7):e162. doi: 10.1136/annrheumdis-2021-220816. Epub 2021 Jun 30.
2
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial.在 CareRA 试验中，对于类风湿关节炎患者，甲氨蝶呤诱导治疗联合或不联合其他 csDMARDs 和临时糖皮质激素的 5 年达标治疗结果。
Ann Rheum Dis. 2021 Aug;80(8):965-973. doi: 10.1136/annrheumdis-2020-219825. Epub 2021 Apr 2.
3
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.在 16 周的治疗后，甲氨蝶呤联合其他 DMARD 与甲氨蝶呤单药治疗在中高剂量糖皮质激素桥接早期类风湿关节炎缓解诱导方面并无优势：CareRA 试验。
Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30.
4
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.甲氨蝶呤联合逐渐减停糖皮质激素缓解诱导（COBRA Slim）与其他强化治疗策略治疗靶向治疗早期类风湿关节炎的疗效比较：CareRA 随机实用开放标签优效性试验的 1 年结果。
Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.
5
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.糖皮质激素、传统和靶向合成的疾病修饰抗风湿药物的疗效：一项系统文献回顾，为 2016 年更新 EULAR 类风湿关节炎管理建议提供信息。
Ann Rheum Dis. 2017 Jun;76(6):1102-1107. doi: 10.1136/annrheumdis-2016-210711. Epub 2017 Mar 29.
6
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir .对Jain和Dhir所著的《关于“CareRA试验中使用或不使用其他传统合成改善病情抗风湿药及短期糖皮质激素的甲氨蝶呤诱导治疗后类风湿关节炎的五年达标治疗结果”的通信》的回复
Ann Rheum Dis. 2023 Jul;82(7):e163. doi: 10.1136/annrheumdis-2021-220857. Epub 2021 Jun 30.
7
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.常规合成疾病修饰抗风湿药物、糖皮质激素和托法替尼的疗效：一项系统文献回顾，为 2013 年更新 EULAR 类风湿关节炎管理建议提供信息。
Ann Rheum Dis. 2014 Mar;73(3):510-5. doi: 10.1136/annrheumdis-2013-204588. Epub 2014 Jan 6.
8
Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.在类风湿关节炎患者的单药治疗和联合治疗中，高剂量与低剂量甲氨蝶呤的短期临床疗效相似。
Arthritis Res Ther. 2017 Nov 22;19(1):258. doi: 10.1186/s13075-017-1468-9.
9
Rheumatoid arthritis: previously untreated early disease.类风湿关节炎：既往未治疗的早期疾病。
BMJ Clin Evid. 2016 Aug 1;2016:1124.
10
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial.甲氨蝶呤联合或不联合早期引入为期6个月的依那西普疗程的桥接糖皮质激素在早期类风湿关节炎中的疗效：为期2年的实用随机CareRA2020试验结果
RMD Open. 2024 Aug 7;10(3):e004535. doi: 10.1136/rmdopen-2024-004535.